Home/Filings/4/0001415889-23-015112
4//SEC Filing

O'Brien Kathrine 4

Accession 0001415889-23-015112

CIK 0001651561other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 6:11 PM ET

Size

8.9 KB

Accession

0001415889-23-015112

Insider Transaction Report

Form 4
Period: 2023-11-03
Transactions
  • Disposition to Issuer

    Common Stock

    2023-11-0320,87975,810 total
  • Disposition to Issuer

    Common Stock

    2023-11-0350,16925,641 total
  • Disposition to Issuer

    Common Stock

    2023-11-0325,6410 total
Footnotes (3)
  • [F1]Upon the consummation of the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger, by and among Tabula Rasa HealthCare, Inc. (the "Company"), Locke Buyer, LLC and Locke Merger Sub, Inc., dated August 5, 2023 (the "Merger Agreement"), 20,879 shares of common stock of the Company ("Common Stock") were converted into the right to receive a cash payment of $219,229.50, representing the product obtained by multiplying (x) the number of shares of Common Stock owned by the reporting person, by (y) the offer price ($10.50).
  • [F2]Upon the consummation of the Merger, pursuant to the Merger Agreement, 50,169 outstanding restricted stock units ("RSUs") were cancelled and converted into the right to receive a cash payment of $526,774.50, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSUs, by (y) the offer price ($10.50).
  • [F3]Upon the consummation of the Merger, pursuant to the Merger Agreement, 25,641 unvested restricted stock awards ("RSAs") were cancelled and converted into the right to receive a cash payment of $269,230.50, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSAs, by (y) the offer price ($10.50).

Issuer

Tabula Rasa HealthCare, Inc.

CIK 0001651561

Entity typeother

Related Parties

1
  • filerCIK 0001754277

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 6:11 PM ET
Size
8.9 KB